🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Clayton S. Lewis

Reaseheath College

ORCID: 0000-0002-4694-9970

Also affiliated with University of Cincinnati Medical Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer”.

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer

Molecular Therapy(2020)10.1016/j.ymthe.2020.05.013
N/A
0DataRank · unranked
23 citations

Harold W. Davis, Zhengtao Chu, Subrahmanya Vallabhapurapu, Clayton S. Lewis, Robert S. Franco +6 more

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

UNC Libraries(2020)10.17615/z9br-cz45
N/A
0DataRank · unranked
0 citations

Janusz Rak, Mariette Adam, Divya Ramchandani, Georg F. Weber, Timofey Sovershaev +14 more

Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update

Cancers(2021)10.3390/cancers13184652
N/A
0DataRank · unranked
16 citations

Clayton S. Lewis, Vladimir Y. Bogdanov, Kateryna Matiash

Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer

Cancers(2025)10.3390/cancers17071224
N/A
0DataRank · unranked
0 citations

Subrahmanya Vallabhapurapu, Eric P. Smith, Harold W. Davis, Clayton S. Lewis, Joseph Ahn +8 more